Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Opens De-Regulation Docket To Collect Ideas For Repealing, Modifying Deficient Rules

This article was originally published in The Pink Sheet Daily

Executive Summary

House oversight committee hears plea for more transparent, predictable regulatory processes at FDA.

You may also be interested in...



Bar Code Rule Could Be Revised Under FDA Reg Review Initiative

Technological advances allow the agency to consider alternatives to the requirements in the current rule, which became effective in 2006.

Bar Code Rule Could Be Revised Under FDA Reg Review Initiative

Technological advances allow the agency to consider alternatives to the requirements in the current rule, which became effective in 2006.

Adjuvants Need Approval Pathway Separate From Vaccines, Industry Tells FDA

Industry is calling on FDA to write separate rules for assessing adjuvants. This would encourage innovation in immunotherapies, the Biotechnology Industry Organization and Pharmaceutical Research and Manufacturers of America contend.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS072153

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel